AC
PCRX icon

AXQ Capital’s Pacira BioSciences PCRX Stock Holding History

AXQ Capital’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Buy
+9,572
New +$226K 0.03% 667
2026
Q1 		– Sell
-15,316
Closed -$396K – 1204
2025
Q4 		$396K Buy
+15,316
New +$364K 0.09% 347

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AXQ Capital's PCRX Position: Q2 2026 in Review

AXQ Capital opened a new position in Pacira BioSciences (PCRX) in Q2 2026: 9,572 shares worth $243K. The stake represents 0.03% of the portfolio and ranks #667 among its holdings. This is a return to the name: AXQ Capital previously reported a position in PCRX as recently as Q4 2025.

AXQ Capital first reported a position in PCRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $396K in Q4 2025. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • AXQ Capital held 9,572 shares of Pacira BioSciences worth $243K as of Q2 2026.
  • Pacira BioSciences was a new AXQ Capital position in Q2 2026.
  • Pacira BioSciences made up 0.03% of AXQ Capital's portfolio in Q2 2026, its #667 holding.
  • AXQ Capital first reported a position in Pacira BioSciences in Q4 2025 and has held it in 2 quarters since.
  • AXQ Capital's Pacira BioSciences position peaked at $396K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.